Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

Thomas M. MacDonald (Lead / Corresponding author), Ian Ford, George Nuki, Isla S. Mackenzie, Raffaele De Caterina, Evelyn Findlay, Jesper Hallas, Christopher J. Hawkey, Stuart Ralston, Matthew Walters, John Webster, John McMurray, Fernando Perez Ruiz, Claudine G. Jennings

    Research output: Contribution to journalArticlepeer-review

    70 Citations (Scopus)
    235 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia'. Together they form a unique fingerprint.

    Medicine & Life Sciences